Stephen W. Wilz, MD

Assistant Professor, Pathology & Laboratory Medicine

Stephen Wilz

Other Positions

  • VA Boston Healthcare System


  • Published on 11/11/2021

    Whiteaker JR, Lundeen RA, Zhao L, Schoenherr RM, Burian A, Huang D, Voytovich U, Wang T, Kennedy JJ, Ivey RG, Lin C, Murillo OD, Lorentzen TD, Thiagarajan M, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Reading JJ, Kaczmarczyk JA, Richardson CW, Garcia-Buntley SS, Bocik W, Hewitt SM, Murray KE, Do N, Brophy M, Wilz SW, Yu H, Ajjarapu S, Boja E, Hiltke T, Rodriguez H, Paulovich AG. Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens. Front Immunol. 2021; 12:765898. PMID: 34858420.

    Read at: PubMed
  • Published on 10/23/2020

    Wilz SW. A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted. Cytokine Growth Factor Rev. 2021 04; 58:49-50. PMID: 33199178.

    Read at: PubMed
  • Published on 8/15/2015

    Wilz SW, Liu D, Liu C, Yang J. Development of a test to identify bladder cancer in the urine of patients using mass spectroscopy and subcellular localization of the detected proteins. Am J Transl Res. 2015; 7(8):1458-66. PMID: 26396676.

    Read at: PubMed
  • Published on 10/1/1993

    Wilz SW, Kurnick JT, Pandolfi F, Rubin RH, Warren HS, Goldstein R, Kersten CM, McCluskey RT. T lymphocyte responses to antigens of gram-negative bacteria in pyelonephritis. Clin Immunol Immunopathol. 1993 Oct; 69(1):36-42. PMID: 8403542.

    Read at: PubMed
  • Published on 11/5/1986

    Kuriyan J, Wilz S, Karplus M, Petsko GA. X-ray structure and refinement of carbon-monoxy (Fe II)-myoglobin at 1.5 A resolution. J Mol Biol. 1986 Nov 05; 192(1):133-54. PMID: 3820301.

    Read at: PubMed

View all profiles